Skip to main content

Table 2 Clinical response

From: Development of a multiparameter flow cytometric assay as a potential biomarker for homologous recombination deficiency in women with high-grade serous ovarian cancer

Best response

HGSOC with gBRCAm

HGSOC without gBRCAm

Total (N)

Median duration of response (range)

Median duration of response (range)

CR

0

0

0

PR

5/5 (100%)

16 months (1017 months)

1/10 (10%)

3 months

6/15 (40%)

SD ≥ 4 months

0/5

3/10

4 months (45 months)

3/15 (20%)

PD

0/5

6/10 (60%)

6/15 (40%)